San Francisco, CA, United States of America

Kathryn H Rosenbluth

This inventor holds 41 USPTO granted patents and 33 published patent applications, plus 2 CIPO patents and 14 EPO patents, primarily in Peripheral Nerve Stimulation. Top assignees: Cala Health, Inc., University of California, Brainlab Ag. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kathryn H Rosenbluth. Retrieved from https://idiyas.com/inventor/kathryn-h-rosenbluth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 41 (Patent Applications = 33)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 10)

EPO Patents = 14 (Patent Applications = 28)

Average Co-Inventor Count = 5.1

ph-index = 16

Forward Citations = 702(Granted Patents)

Company Filing History:

University of California

Voyager Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

Peripheral Nerve Stimulation

Osteoarthritis Treatment

Tremor Control

Biomedical Targeting

Neuromodulation Devices

Cardiac Dysfunction

Inflammatory Bowel Disease

Overactive Bladder

Transcutaneous Nerve Stimulation

Detachable Therapy

Sleep Apnea Correction

Infusion Parameter

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12752111 - Three nerve stimulation system for tremor reduction (2026-10-06),

2. 12746390 - Parameter variation in neural stimulation (2026-09-29),

3. 12741137 - Devices and methods for controlling tremor (2026-09-22),

4. 12575780 - Systems, devices, and method for the treatment of osteoarthritis (2026-03-17),

5. 12453853 - Multi-modal stimulation for treating tremor (2025-10-28),

6. 12420082 - Systems and methods for peripheral nerve stimulation in the finger or hand (2025-09-23),

7. 12357824 - Systems, methods and devices for peripheral neuromodulation (2025-07-15),

8. 12318183 - Methods for biomedical targeting and delivery and devices and systems for practicing the same (2025-06-03),

9. 12233265 - Systems and methods for treating cardiac dysfunction through peripheral nerve stimulation (2025-02-25),

10. 12161865 - Systems, methods and devices for peripheral neuromodulation (2024-12-10),

11. 12161858 - Devices and methods for controlling tremor (2024-12-10),

12. 12157001 - Systems and methods for peripheral nerve stimulation to treat tremor with detachable therapy and monitoring units (2024-12-03),

13. 12109413 - Systems and methods for peripheral nerve stimulation to treat tremor (2024-10-08),

14. 11918806 - Systems, methods and devices for peripheral neuromodulation of the leg (2024-03-05),

15. 11857778 - Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation (2024-01-02),

Title: Innovations by Kathryn H. Rosenbluth: Pioneering Cardiac Treatments

Introduction

Kathryn H. Rosenbluth, based in San Francisco, CA, is an accomplished inventor with an impressive portfolio of 33 patents. Her groundbreaking work in the field of medical technology, particularly related to cardiac dysfunction and peripheral nerve stimulation, has made significant impacts in healthcare.

Latest Patents

Among her latest patents are innovative systems and methods for treating cardiac dysfunction through peripheral nerve stimulation. These systems are tailored for the treatment and prevention of cardiac dysrhythmias and hypertension, focusing specifically on conditions like atrial fibrillation. Additionally, she has developed systems and methods for peripheral neuromodulation, where a wearable device with an electrically conductive skin interface stimulates underlying nerves from a transcutaneous surface stimulator. This versatile device accommodates various user sizes and targets critical nerves such as the peroneal, femoral, saphenous, and tibial nerves. The stimulation techniques may include burst stimulation and utilize inputs relating to autonomic nervous system activity.

Career Highlights

Throughout her career, Kathryn has contributed to notable organizations, including Cala Health, Inc. and the University of California. Her work has focused on bridging the gap between neuromodulation and its applications in cardiac health, showcasing her innovative spirit and dedication to enhancing medical treatment methodologies.

Collaborations

Kathryn has collaborated with several intelligent minds in her field, including Samuel Richard Hamner and Serena HanYing Wong. These partnerships have likely enriched her research and development process, promoting enhanced innovation and effectiveness in her work.

Conclusion

Kathryn H. Rosenbluth stands out as a prominent inventor, consistently pushing the boundaries of innovation in cardiac treatment technologies. Her contributions significantly enhance patient care, demonstrating the power of invention and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.